Effects of statins on vascular structure and function: A systematic review
Autor: | Ethan M Balk, Joseph Lau, Harmon S. Jordan, Bruce Kupelnick, Richard H. Karas, Priscilla Chew |
---|---|
Rok vydání: | 2004 |
Předmět: |
Tunica media
medicine.medical_specialty Endothelium Coronary Angiography Placebo Internal medicine medicine Humans cardiovascular diseases business.industry nutritional and metabolic diseases General Medicine Tunica intima Lipids Confidence interval Surgery medicine.anatomical_structure Cardiovascular Diseases Relative risk Disease Progression Cardiology lipids (amino acids peptides and proteins) Endothelium Vascular Hydroxymethylglutaryl-CoA Reductase Inhibitors Tunica Intima Tunica Media business Blood vessel Artery |
Zdroj: | The American Journal of Medicine. 117:775-790 |
ISSN: | 0002-9343 |
DOI: | 10.1016/j.amjmed.2004.05.026 |
Popis: | PURPOSE: Statins reduce cardiovascular events by more than can be explained by their effects on lipids. We conducted a systematic review of how statins affect vascular structure and function, differences among statins, and correlations between the effects of statins on vascular outcomes and either lipid levels or cardiovascular outcomes. METHODS: We primarily searched MEDLINE (1980 to March 2004) to identify all studies with at least 10 subjects that reported the effects of currently available statins on coronary artery stenosis, carotid intima-media thickness, and endothelial function (excluding studies of drug combinations and subjects with organ transplants). Meta-analyses were performed when feasible. RESULTS: Statins decrease the progression and increase the regression of coronary artery lesions and luminal narrowing. Compared with placebo, statins decrease the likelihood of coronary artery restenosis (summary risk ratio = 0.85; 95% confidence interval: 0.77 to 0.95). Statins appear to slow the progression of carotid artery intima-media thickness. Although the effect of statins on coronary endothelial function is uncertain, statins appear to improve peripheral endothelial function. There is no conclusive evidence to suggest that individual statins differ in their effects on these outcomes. Studies generally found weak or no correlation between the effects of statins on vascular outcomes and lipid levels. No study showed a correlation between vascular effect and clinical outcome. CONCLUSION: Statins slow the progression of, and may reverse, atherosclerosis. The magnitude of these effects, however, is small compared with the effects of statins on cardiovascular events. Statins also improve measures of vascular function, which may contribute to their clinical benefits. There is insufficient evidence to suggest that individual statins differ in their vascular effects. |
Databáze: | OpenAIRE |
Externí odkaz: |